SG165194A1 - Point of care test for the detection of exposure to hev immunoglobulin a (iga) - Google Patents

Point of care test for the detection of exposure to hev immunoglobulin a (iga)

Info

Publication number
SG165194A1
SG165194A1 SG200901939-9A SG2009019399A SG165194A1 SG 165194 A1 SG165194 A1 SG 165194A1 SG 2009019399 A SG2009019399 A SG 2009019399A SG 165194 A1 SG165194 A1 SG 165194A1
Authority
SG
Singapore
Prior art keywords
hev
iga
point
immunoglobulin
exposure
Prior art date
Application number
SG200901939-9A
Inventor
Bijon Kumar Sil
Tan Yun Ying
Original Assignee
Mp Biomedicals Asia Pacific Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mp Biomedicals Asia Pacific Pte Ltd filed Critical Mp Biomedicals Asia Pacific Pte Ltd
Priority to SG200901939-9A priority Critical patent/SG165194A1/en
Priority to PCT/SG2010/000102 priority patent/WO2010107398A1/en
Publication of SG165194A1 publication Critical patent/SG165194A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a point of care test ("POCT") for detecting IgA in a subject that is specific for an anti-hepatitis E virus ("HEV") or equivalent thereof. The method comprises contacting a biological sample(s) from the subject with a mixture of HEV specific immunogenic components; and determining the presence of a complex that forms between a binding partner in the biological sample and a HEV specific immunogenic component; and characterizing the binding partner in the complex with an anti-IgA antibody conjugated with gold colloid using reverse flow technology.
SG200901939-9A 2009-03-20 2009-03-20 Point of care test for the detection of exposure to hev immunoglobulin a (iga) SG165194A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SG200901939-9A SG165194A1 (en) 2009-03-20 2009-03-20 Point of care test for the detection of exposure to hev immunoglobulin a (iga)
PCT/SG2010/000102 WO2010107398A1 (en) 2009-03-20 2010-03-18 Point of care test for the detection of exposure to hev immunoglobulin a (iga)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200901939-9A SG165194A1 (en) 2009-03-20 2009-03-20 Point of care test for the detection of exposure to hev immunoglobulin a (iga)

Publications (1)

Publication Number Publication Date
SG165194A1 true SG165194A1 (en) 2010-10-28

Family

ID=42739876

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200901939-9A SG165194A1 (en) 2009-03-20 2009-03-20 Point of care test for the detection of exposure to hev immunoglobulin a (iga)

Country Status (2)

Country Link
SG (1) SG165194A1 (en)
WO (1) WO2010107398A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102288759A (en) * 2011-07-29 2011-12-21 北京中检安泰诊断科技有限公司 Hepatitis E virus (HEV) IgG antibody colloidal gold method detection kit and preparation method thereof
CN104090105A (en) * 2014-07-10 2014-10-08 广州市丰华生物工程有限公司 Method and kit for detecting hepatitis E virus (HEV) antibody and method for preparing kit
CN104792987B (en) * 2015-04-29 2017-03-08 中国食品药品检定研究院 For diagnosing method and the kit of hepatitis e virus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234542A1 (en) * 2001-05-07 2004-11-25 Xiang-Jin Meng Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
SG157244A1 (en) * 2008-05-15 2009-12-29 Mp Biomedicals Asia Pacific Pte Ltd Point of care test for the detection of exposure or immunity to dengue virus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CLINICAL SIGNIFICANCE OF ANTI-HEV IGA IN DIAGNOSIS OF ACUTE GENOTYPE 4 HEPATITIS E VIRUS INFECTION NEGATIVE FOR ANTI-HEV IGM *
Comparison of a New Immunochromatographic Test to Enzyme- Linked Immunosorbent Assay for Rapid Detection of Immunoglobulin M Antibodies to Hepatitis E Virus in Human Sera *
SIGNIFICANCE OF SERUM IGA IN PATIENTS WITH ACUTE HEPATITIS E VIRUS INFECTION *

Also Published As

Publication number Publication date
WO2010107398A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
SG157244A1 (en) Point of care test for the detection of exposure or immunity to dengue virus
Soler et al. Label-free SPR detection of gluten peptides in urine for non-invasive celiac disease follow-up
MX2009004460A (en) Immunoassay of analytes in samples containing endogenous anti-analyte antibodies.
SG135990A1 (en) Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody
BR112017002209A2 (en) method and kit for detecting a dengue virus infection
TR201818881T4 (en) Signal Amplification Immunoassays
DE602005009819D1 (en) METHOD FOR DETECTING INFECTIONS WITH MYCOBACTERIES
Vaquer et al. Nanoparticle transfer biosensors for the non-invasive detection of SARS-CoV-2 antigens trapped in surgical face masks
RS54249B1 (en) Methods for detecting anti-drug antibodies
RU2013138482A (en) METHODS AND DEVICE FOR DETECTING GLUTEN SENSITIVITY AND ITS DIFFERENTIATION WITH CELIACIA
MX2007006895A (en) Detection of a therapeutic antibody in an experimental animal.
EA200700345A1 (en) ENRICHED ANTIBODY FOR THE IDENTIFICATION OF MYCOBACTERIAL INFECTION, METHODS OF APPLICATION AND DIAGNOSTIC TESTS USING SUCH ANTIBODY
Bong et al. Competitive immunoassay of SARS-CoV-2 using pig sera-derived anti-SARS-CoV-2 antibodies
WO2021046316A3 (en) Anti-drug antibody assay
SG165194A1 (en) Point of care test for the detection of exposure to hev immunoglobulin a (iga)
ATE519108T1 (en) DETECTION OF ANALYTES IN FECAL SAMPLES
Liang et al. Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms
WO2008067007A3 (en) A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample
WO2008067008A3 (en) A method for the quantitative evaluation of sex hormones in a serum sample
WO2008067003A3 (en) A method to detect virus related immunological markers for the diagnosis of respiratory tract infections
GB2454852A (en) A method for screening of infectious agents in blood
RU2012127077A (en) METHOD OF IMMUNOCHROMATOGRAPHIC ANALYSIS FOR SERODIAGNOSTICS
TWM537659U (en) Test piece device for rapid inspection
Pektas et al. Evaluation of serological results of patients with suspected toxoplasmosis
ATE520985T1 (en) METHOD FOR DETERMINING ANTIGEN AND ANTIBODIES AGAINST THE ANTIGEN